转移性乳腺癌 (MBC)的临床试验
总计16121个结果
-
ZionexaGE Healthcare; Simbec-Orion Group; Keosys招聘中
-
Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.招聘中
-
University of LouisvilleJames Graham Brown Cancer Center招聘中
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi Sankyo, Inc.招聘中
-
SOLTI Breast Cancer Research GroupRoche Pharma AG招聘中
-
Shandong Cancer Hospital and Institute尚未招聘
-
Minerva Biotechnologies CorporationCity of Hope Medical Center招聘中
-
Medical College of WisconsinLoyola University Chicago招聘中
-
ETOP IBCSG Partners FoundationBreast International Group完全的
-
UNICANCERAstraZeneca; Fondation ARC主动,不招人
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Bayer; Novartis Pharmaceuticals; Rutgers Cancer Institute of New...完全的
-
Gilead SciencesParexel; Iqvia Pty Ltd; Medidata Solutions主动,不招人
-
Eli Lilly and Company可用的转移性乳腺癌澳大利亚, 加拿大, 埃及, 印度, 意大利, 大韩民国, 马来西亚, 新加坡, 南非, 西班牙, 瑞士, 台湾, 泰国, 英国
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Foundation Medicine主动,不招人
-
Allarity TherapeuticsDanish Breast Cancer Cooperative Group; Smerud Medical Research International AS主动,不招人
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Hellenic Cooperative Oncology GroupHellenic Society of Medical Oncology主动,不招人
-
Spanish Breast Cancer Research GroupBristol-Myers Squibb完全的
-
MedSIR完全的
-
SOLTI Breast Cancer Research GroupNovartis; Roche Pharma AG; Guardant Health, Inc.主动,不招人
-
Japan Breast Cancer Research GroupChugai Pharmaceutical完全的
-
University of Maryland, BaltimoreGenentech, Inc.终止
-
Abramson Cancer Center of the University of Pennsylvania终止
-
Seoul National University HospitalSeoul National University Bundang Hospital; Korean Cancer Study Group (KCSG); Eisai Korea Inc.; Ono...主动,不招人
-
Eisai Inc.Halozyme Therapeutics终止